Int Arch Med. 2012 Feb 8;5:5.

Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.

Rodriguez JP, Murphy MP, Hong S, Madrigal M, March KL, Minev B, Harman RJ, Chen CS, Timmons RB, Marleau AM, Riordan NH.

Source

Institute for Molecular Medicine, Huntington Beach, CA, USA. amarleau@immed.org.

Abstract

ABSTRACT: Advancements in rheumatoid arthritis (RA) treatment protocols and introduction of targeted biological therapies have markedly improved patient outcomes, despite this, up to 50% of patients still fail to achieve a significant clinical response. In veterinary medicine, stem cell therapy in the form of autologous stromal vascular fraction (SVF) is an accepted therapeutic modality for degenerative conditions with 80% improvement and no serious treatment associated adverse events reported. Clinical translation of SVF therapy relies on confirmation of veterinary findings in targeted patient populations. Here we describe the rationale and preclinical data supporting the use of autologous SVF in treatment of RA, as well as provide 1, 3, 6, and 13 month safety outcomes in 13 RA patients treated with this approach.

PMID:: 22313603; [PubMed - in process]
PMCID:: PMC3296619

Free PMC Article

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). [J Rheumatol. 2003]
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK. J Rheumatol. 2003 Dec; 30(12):2563-71.
Review The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis. [Health Technol Assess. 2004]
Review The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
Clark W, Jobanputra P, Barton P, Burls A. Health Technol Assess. 2004 May; 8(18):iii-iv, ix-x, 1-105.
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. [Stroke. 2003]
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, et al. Stroke. 2003 Aug; 34(8):e109-37. Epub 2003 Jul 17.
Review Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. [J Transl Med. 2009]
Review Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis.
Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, et al. J Transl Med. 2009 Apr 24; 7:29. Epub 2009 Apr 24.
Review High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review. [Hum Immunol. 2002]
Review High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review.
Verburg RJ, Toes RE, Fibbe WE, Breedveld FC, van Laar JM. Hum Immunol. 2002 Aug; 63(8):627-37.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale...
Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.
Int Arch Med. 2012 Feb 8 ;5:5.

PubMed
Nicardipine in the prevention of cerebral infarction.
Nicardipine in the prevention of cerebral infarction.
Clin Ther. 1990 Jul-Aug ;12(4):344-51.

PubMed
Resource flows for health care: Namibia reproductive health sub-accounts.
Resource flows for health care: Namibia reproductive health sub-accounts.
Int Arch Med. 2011 Dec 24 ;4(1):41.

PubMed
Fibrin glue: the perfect operative sealant?
Fibrin glue: the perfect operative sealant?
Transfusion. 1990 Oct ;30(8):741-7.

PubMed
Frequency and factors influencing publication of abstracts presented at three ma...
Frequency and factors influencing publication of abstracts presented at three major nephrology meetings.
Int Arch Med. 2011 Dec 6 ;4(1):40.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.

Source

Abstract

LinkOut - more resources

Full Text Sources

Other Literature Sources

Libraries

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information